Stirlingshire Investments’s Counterpoint Quantitative Equity ETF CPAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$586K Sell
11,284
-389
-3% -$18.6K 0.43% 65
2026
Q1
$488K Sell
11,673
-1,750
-13% -$75.5K 0.43% 60
2025
Q4
$538K Buy
+13,423
New +$532K 0.48% 57

Other funds holding CPAI

Stirlingshire Investments's CPAI Position: Q2 2026 in Review

Stirlingshire Investments reduced its Counterpoint Quantitative Equity ETF (CPAI) stake by 3.3% in Q2 2026, selling an estimated $18.6K and leaving 11,284 shares worth $586K. The position accounts for 0.43% of the portfolio, ranked #65.

Stirlingshire Investments first reported a position in CPAI in Q4 2025 and has held it in 3 quarters since. 54 funds tracked by Wall St. Rank hold CPAI as of Q2 2026.

  • Stirlingshire Investments held 11,284 shares of Counterpoint Quantitative Equity ETF worth $586K as of Q2 2026.
  • Stirlingshire Investments sold 389 Counterpoint Quantitative Equity ETF shares in Q2 2026, an estimated $18.6K.
  • Counterpoint Quantitative Equity ETF made up 0.43% of Stirlingshire Investments's portfolio in Q2 2026, its #65 holding.
  • Stirlingshire Investments first reported a position in Counterpoint Quantitative Equity ETF in Q4 2025 and has held it in 3 quarters since.
  • 54 funds tracked by Wall St. Rank held Counterpoint Quantitative Equity ETF as of Q2 2026.

Based on Stirlingshire Investments's 13F filing for Q2 2026, filed 31 Jul 2026.